Edmond de Rothschild Holding’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Edmond de Rothschild Holding’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-396	Closed	-$21K	–	855
2017 Q4	$21K	Hold	396	–	–	﹤0.01%	711
2017 Q3	$23K	Hold	396	–	–	﹤0.01%	726
2017 Q2	$24K	Sell	396 -1,371	-78%	-$78.1K	﹤0.01%	725
2017 Q1	$96K	Buy	+1,767	New	+$87K	﹤0.01%	564

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Edmond de Rothschild Holding's BIVV Position: Q1 2018 in Review

Edmond de Rothschild Holding sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 396 shares — an estimated $21K sold.

Edmond de Rothschild Holding first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $96K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Edmond de Rothschild Holding reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Edmond de Rothschild Holding sold 396 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $21K.
Edmond de Rothschild Holding first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Edmond de Rothschild Holding's Bioverativ Inc. Common Stock position peaked at $96K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2018, filed 15 May 2018.